Clinical Trial Update: Cisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric Carcinomas [Phase 2]

View source ↗

Summary

Phase 2 study evaluating cisplatin and irinotecan chemotherapy followed by ZD 1839 (Iressa) in patients with esophageal or gastric carcinomas. The trial status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Camptosar (irinotecan)
• Iressa (gefitinib)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Esophageal Cancer, Gastric Cancer | Phase 2 | Status: COMPLETED